Chemistry:Dimiracetam
From HandWiki
| Names | |
|---|---|
| IUPAC name
(RS)-3,6,7,7a-Tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C6H8N2O2 | |
| Molar mass | 140.142 g·mol−1 |
| Pharmacology | |
| Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Tracking categories (test):
Dimiracetam is a nootropic drug of the racetam family,[1] derivatives of which may have application in the treatment of neuropathic pain.[2]
Legality
Australia
Dimiracetam is a schedule 4 substance in Australia under the Poisons Standard (February 2020).[3] A schedule 4 substance is classified as "Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription."[3]
References
- ↑ "Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers". Journal of Medicinal Chemistry 36 (26): 4214–20. December 1993. doi:10.1021/jm00078a011. PMID 8277504.
- ↑ "Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain". Bioorganic & Medicinal Chemistry 16 (6): 3224–32. March 2008. doi:10.1016/j.bmc.2007.12.015. PMID 18171618.
- ↑ 3.0 3.1 Poisons Standard February 2020. comlaw.gov.au
